EP1915993B1 — Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
Assigned to Novartis AG · Expires 2013-07-10 · 13y expired
What this patent protects
A pharmaceutical composition comprising the renin inhibitor aliskiren or a pharmaceutically acceptable salt thereof and at least one therapeutic agent selected from the group consisting of a diuretic or a pharmaceutically acceptable salt thereof, and a carrier
USPTO Abstract
A pharmaceutical composition comprising the renin inhibitor aliskiren or a pharmaceutically acceptable salt thereof and at least one therapeutic agent selected from the group consisting of a diuretic or a pharmaceutically acceptable salt thereof, and a carrier
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.